KIT (CD117) expression in benign and malignant sweat gland tumors

American Journal of Dermatopathology

Volumn 37, Issue 12, 2015, Pages 898-905

  Nishida, Haruto ^a   Daa, Tsutomu ^a   Kashima, Kenji ^a   Arakane, Motoki ^a   Urabe, Shogo ^b   Yoshikawa, Yasuji ^c   Gamachi, Ayako ^d   Yokoyama, Shigeo ^a  

^a OITA UNIVERSITY   (Japan)

^b OITA PREFECTURAL HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION BEPPU MEDICAL CENTER   (Japan)

^d Department of Neurosurgery Almeida Memorial Hospital   (Japan)

Author keywords

immunohistochemistry; KIT (CD117); mutation; sweat gland tumor; tumorigenesis

Indexed keywords

STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

ADENOID CYSTIC CARCINOMA; ADOLESCENT; ADULT; AGED; APOCRINE CARCINOMA; ARTICLE; CHILD; CONTROLLED STUDY; ECCRINE POROCARCINOMA; ECCRINE POROMA; EXON; FEMALE; GENE MUTATION; HIDRADENOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIXED TUMOR; MYOEPITHELIUM CELL; PAGET SKIN DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECRETORY CELL; SINGLE STRAND CONFORMATION POLYMORPHISM; SWEAT GLAND CANCER; SWEAT GLAND TUMOR; SYRINGOMA; BIOSYNTHESIS; DNA MUTATIONAL ANALYSIS; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-KIT; SWEAT GLAND NEOPLASMS; YOUNG ADULT;

EID: 84949316696     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0000000000000301     Document Type: Article

References (14)

1. Ni S, Huang D, Chen X, et al. c-kit gene mutation and CD117 expression in human anorectal melanomas. Hum Pathol. 2012;43:801-807.
2. Lammie A, Drobnjak M, Gerald W, et al. Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem. 1994; 42:1417-1425.
3. Went PT, Dirnhofer S, Bundi M, et al. Prevalence of KIT expression in human tumors. J Clin Oncol. 2004;22:4514-4522.
4. Johnson DB, Sosman JA. Update on the targeted therapy of melanoma. Curr Treat Options Oncol. 2013;14:280-292.
5. Brown MC, Casasola RJ. Complete response in a melanoma patient treated with imatinib. J Laryngol Otol. 2012;126:638-640.
6. Ramakrishnan R, Chaudhry IH, Ramdial P, et al. Primary cutaneous adenoid cystic carcinoma: a clinicopathologic and immunohistochemical study of 27 cases. Am J Surg Pathol. 2013;37:1603-1611.
7. Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997-4013.
8. Sihto H, Sarlomo-Rikala M, Tynninen O, et al. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J Clin Oncol. 2005;23:49-57.
9. Mino M, Pilch BZ, Faquin WC. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol. 2003;16:1224-1231.
10. Jeng YM, Lin CY, Hsu HC. Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett. 2000; 154:107-111.
11. Freier K, Flechtenmacher C, Walch A, et al. Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland. Oral Oncol. 2005;41:934-939.
12. Crisi GM, Marconi SA, Makari-Judson G, et al. Expression of c-kit in adenoid cystic carcinoma of the breast. Am J Clin Pathol. 2005;124: 733-739.
13. Vila L, Liu H, Al-Quran SZ, et al. Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland. Mod Pathol. 2009;22:1296-1302.
14. Faivre S, Raymond E, Casiraghi O, et al. Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands. J Clin Oncol. 2005;23:6271-6273.